Texas Introduces New Bill Targeting Med Spas: House Bill 3749

Mar 7, 2025 | News, State-Specific Regulations

The Texas legislature is taking a closer look at the med spa industry with the introduction of House Bill 3749, proposed by Representative Angelia Orr on March 4, 2025. This bill is a direct response to growing concerns over patient safety in medical spas,...

Court Ruling Backs FDA, Blocks Compounded Versions of Eli Lilly’s Weight-Loss Drug

Mar 6, 2025 | News

In a recent legal development, a U.S. federal judge has denied an injunction that would have allowed compounding pharmacies to continue producing copies of Eli Lilly’s weight-loss medication, Zepbound. This decision stems from an October lawsuit filed by a...

Treasury Department Suspends Enforcement of Corporate Transparency Act for U.S. Citizens and Domestic Companies

Mar 4, 2025 | News

On March 2, 2025, the U.S. Treasury Department announced a major shift in its enforcement of the Corporate Transparency Act (CTA), declaring that it will no longer impose penalties or fines on U.S. citizens and domestic reporting companies under the beneficial...

FinCEN Extends Beneficial Ownership Information Reporting Deadline by 30 Days

Feb 28, 2025 | Legal Compliance, News

The Financial Crimes Enforcement Network (FinCEN), which is a bureau of the U.S. Department of the Treasury (DOT), has announced an extension of the Beneficial Ownership Information (BOI) reporting deadline by 30 days, following a February 18, 2025 court ruling that...

Understanding the USPTO’s Updated Trademark Filing Process and Fee Structure for 2025

Feb 24, 2025 | Legal Compliance, News

The United States Patent and Trademark Office (USPTO) has recently announced significant updates to its trademark application process and fee structure. Effective February 18, 2025, these changes impact both domestic and international trademark applicants. This blog...

Urgent Update – FDA Ends Semaglutide Shortage: What This Means for Med Spas

Feb 21, 2025 | News

The FDA has officially declared an end to the shortage of semaglutide, the active ingredient in the popular medications Ozempic and Wegovy. This announcement signals a significant shift in how compounding pharmacies, medical spas, and other businesses can offer these...